Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Satoshi Shiono

Showing results (131-140 of 153) with videos related to

Pageof 16
Sort By:
Lung Cancer (Amsterdam, Netherlands)|February 19, 2017
A prospective, multi-institutional phase II study of induction chemoradiotherapy followed by surgery in patients with non-small cell lung cancer involving the chest wall (CJLSG0801)Koji Kawaguchi, Kohei Yokoi, Hiroshi Niwa, et al.
The Annals of Thoracic Surgery|August 12, 2014
Trimodality therapy for lung cancer with chest wall invasion: initial results of a phase II studyKoji Kawaguchi, Kohei Yokoi, Hiroshi Niwa, et al.
Japanese Journal of Clinical Oncology|October 24, 2024
Protocol summary of a randomized phase III study: comparing systemic therapy with and without debulking surgery (primary tumour resection) for clinical stage IVA (cT1-2bN0-1M1a) non-small cell lung cancer with radiologically undetermined pleural dissemination JCOG2103 (DEBULK-LUNG)Yuta Sekino, Tomoyuki Hishida, Hiroshige Yoshioka, et al.
Japanese Journal of Clinical Oncology|November 4, 2020
Recent advances and future perspectives in adjuvant and neoadjuvant immunotherapies for lung cancerMasaya Yotsukura, Kazuo Nakagawa, Kenji Suzuki, et al.
Japanese Journal of Clinical Oncology|January 28, 2021
Surgical challenges in multimodal treatment of N2-stage IIIA non-small cell lung cancerMasafumi Yamaguchi, Kazuo Nakagawa, Kenji Suzuki, et al.
Annals of Surgical Oncology|June 18, 2022
Time to Incurable Recurrence for Patients Treated With Pulmonary Metastasectomy for Colorectal CancerHaruhisa Matsuguma, Mingyon Mun, Atsushi Sano, et al.
Annals of Surgical Oncology|May 21, 2022
ASO Author Reflections: New Indicator to Demonstrate Cure Probability: Time to Incurable RecurrenceHaruhisa Matsuguma, Mingyon Mun, Atsushi Sano, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|December 14, 2017
A prospective 5-year follow-up study after limited resection for lung cancer with ground-glass opacityMotoyasu Sagawa, Hiroyuki Oizumi, Hiroyuki Suzuki, et al.
[Nihon Koshu Eisei Zasshi] Japanese Journal of Public Health|October 11, 2023
Development of a partnership between academia, community, and government in response to the 2022 mpox outbreak in JapanMio Kato, Fumi Yoshimatsu, Tomonori Yamamoto, et al.
Scientific Reports|September 11, 2024
A prospective 10-year follow-up study after sublobar resection for ground-glass opacity-dominant lung cancerHirohisa Kato, Satoshi Shiono, Hiroyuki Suzuki, et al.
Pageof 16

Showing results (131-140 of 153) with videos related to

Sort By:
Pageof 16
Lung Cancer (Amsterdam, Netherlands)|February 19, 2017
A prospective, multi-institutional phase II study of induction chemoradiotherapy followed by surgery in patients with non-small cell lung cancer involving the chest wall (CJLSG0801)Koji Kawaguchi, Kohei Yokoi, Hiroshi Niwa, et al.
The Annals of Thoracic Surgery|August 12, 2014
Trimodality therapy for lung cancer with chest wall invasion: initial results of a phase II studyKoji Kawaguchi, Kohei Yokoi, Hiroshi Niwa, et al.
Japanese Journal of Clinical Oncology|October 24, 2024
Protocol summary of a randomized phase III study: comparing systemic therapy with and without debulking surgery (primary tumour resection) for clinical stage IVA (cT1-2bN0-1M1a) non-small cell lung cancer with radiologically undetermined pleural dissemination JCOG2103 (DEBULK-LUNG)Yuta Sekino, Tomoyuki Hishida, Hiroshige Yoshioka, et al.
Japanese Journal of Clinical Oncology|November 4, 2020
Recent advances and future perspectives in adjuvant and neoadjuvant immunotherapies for lung cancerMasaya Yotsukura, Kazuo Nakagawa, Kenji Suzuki, et al.
Japanese Journal of Clinical Oncology|January 28, 2021
Surgical challenges in multimodal treatment of N2-stage IIIA non-small cell lung cancerMasafumi Yamaguchi, Kazuo Nakagawa, Kenji Suzuki, et al.
Annals of Surgical Oncology|June 18, 2022
Time to Incurable Recurrence for Patients Treated With Pulmonary Metastasectomy for Colorectal CancerHaruhisa Matsuguma, Mingyon Mun, Atsushi Sano, et al.
Annals of Surgical Oncology|May 21, 2022
ASO Author Reflections: New Indicator to Demonstrate Cure Probability: Time to Incurable RecurrenceHaruhisa Matsuguma, Mingyon Mun, Atsushi Sano, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|December 14, 2017
A prospective 5-year follow-up study after limited resection for lung cancer with ground-glass opacityMotoyasu Sagawa, Hiroyuki Oizumi, Hiroyuki Suzuki, et al.
[Nihon Koshu Eisei Zasshi] Japanese Journal of Public Health|October 11, 2023
Development of a partnership between academia, community, and government in response to the 2022 mpox outbreak in JapanMio Kato, Fumi Yoshimatsu, Tomonori Yamamoto, et al.
Scientific Reports|September 11, 2024
A prospective 10-year follow-up study after sublobar resection for ground-glass opacity-dominant lung cancerHirohisa Kato, Satoshi Shiono, Hiroyuki Suzuki, et al.
Pageof 16